2021
DOI: 10.1007/s10904-021-02118-7
|View full text |Cite
|
Sign up to set email alerts
|

Opportunities and Challenges in Biomedical Applications of Metal–Organic Frameworks

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
20
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 47 publications
(20 citation statements)
references
References 171 publications
0
20
0
Order By: Relevance
“…Despite promising results suggesting minimal cytotoxicity and toxicity of MOFs, there are still limited in vivo toxicity studies on different MOF materials [ 191 , 194 ]. Even so, preliminary studies identified that parameters such as size, shape, functionalization, and solvent systems may influence MOFs biodistribution and toxicity, as well as the use of toxic metals in the composition, such as lead, arsenic, cadmium, and chromium, which may promote severe health issues [ 196 ]. Nevertheless, further comprehensive and in-depth research of the long-term impacts of MOFs and their combined therapies may be necessary to better determine their biosafety.…”
Section: Challenges and Opportunitiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite promising results suggesting minimal cytotoxicity and toxicity of MOFs, there are still limited in vivo toxicity studies on different MOF materials [ 191 , 194 ]. Even so, preliminary studies identified that parameters such as size, shape, functionalization, and solvent systems may influence MOFs biodistribution and toxicity, as well as the use of toxic metals in the composition, such as lead, arsenic, cadmium, and chromium, which may promote severe health issues [ 196 ]. Nevertheless, further comprehensive and in-depth research of the long-term impacts of MOFs and their combined therapies may be necessary to better determine their biosafety.…”
Section: Challenges and Opportunitiesmentioning
confidence: 99%
“…As a result, there is a need for novel or optimized functionalization methods that allow for the incorporation of a range of therapeutics to produce more suited and sophisticated MOFs for therapeutic applications. Moreover, the pharmacokinetics, degradation mechanisms, and toxicity of MOFs are still poorly understood, and further research is needed to develop and design novel MOF nanocomposites with higher stability, biocompatibility, and therapeutic performance [ 196 , 200 ]. Validation and standardization of testing procedures are also critical for the field's development [ 191 ].…”
Section: Challenges and Opportunitiesmentioning
confidence: 99%
“…Numerous techniques have been employed for illicit drug detection in forensic toxicology, such as nuclear magnetic resonance [ 4 , 5 ], mass spectrometry [ 6 , 7 ], combined gas chromatography/mass spectrometry (GC-MS) [ 8 , 9 ], high-performance liquid chromatography (HPLC) [ 10 ], and X-ray powder diffraction [ 11 ]. In spite of their high molecular specificity, the aforementioned methods are typically centralized and require extensive sample preparation, expensive reagents, trained personnel, and time-consuming analysis.…”
Section: Introductionmentioning
confidence: 99%
“…Nanotechnology has allowed advances in monitoring, diagnosis, prognosis, and proposing effective treatments [ 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ]. In this sense, biosensors based on nanomaterials have accurate detection, efficient monitoring, and fast but reliable imaging [ 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%